golimumab

G2O1L1I1M3U1M3A1B3
US/ɡoʊˈlɪm.jəˌmæb/

noun

A genetically engineered monoclonal antibody (trademark Simponi) that inhibits the activity of tumor necrosis factor and is administered by subcutaneous injection to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis.

Scrabble 16
Ask AI about this wordChatGPTClaudePerplexityGoogle AIGrok

Meanings

noungolimumab (uncountable)
  1. uncountablemedicineA genetically engineered monoclonal antibody (trademark Simponi) that inhibits the activity of tumor necrosis factor and is administered by subcutaneous injection to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis.

Origin

From [Term?] + -lim- (“immunomodulating”) + -umab (“human monoclonal antibody”).

Full word history & related roots →
Cite this entry
APA

golimumab. (n.d.). In WatkinsX Dictionary. Retrieved November 3, 2026, from https://dictionary.watkinsx.com/word/golimumab

MLA

“golimumab.” WatkinsX Dictionary, https://dictionary.watkinsx.com/word/golimumab. Accessed November 3, 2026.

Chicago

WatkinsX Dictionary, s.v. “golimumab,” accessed November 3, 2026, https://dictionary.watkinsx.com/word/golimumab.

Source: golimumab on Wiktionary, CC BY-SA 4.0.